222 related articles for article (PubMed ID: 9500652)
1. Cytologic features of synovial sarcoma with emphasis on the monophasic fibrous variant: a morphologic and immunocytochemical analysis of bcl-2 protein expression.
Viguer JM; Jiménez-Heffernan JA; Vicandi B; López-Ferrer P; Gamallo C
Cancer; 1998 Feb; 84(1):50-6. PubMed ID: 9500652
[TBL] [Abstract][Full Text] [Related]
2. Cytohistologic correlations in 56 synovial sarcomas in 36 patients: the Institut Curie experience.
Klijanienko J; Caillaud JM; Lagacé R; Vielh P
Diagn Cytopathol; 2002 Aug; 27(2):96-102. PubMed ID: 12203876
[TBL] [Abstract][Full Text] [Related]
3. Monophasic synovial sarcoma: a cytologic spectrum.
Ewing CA; Zakowski MF; Lin O
Diagn Cytopathol; 2004 Jan; 30(1):19-23. PubMed ID: 14696140
[TBL] [Abstract][Full Text] [Related]
4. Synovial sarcoma with relevant immunocytochemistry and special emphasis on the monophasic fibrous variant.
Kottu R; Prayaga AK
J Cytol; 2010 Apr; 27(2):47-50. PubMed ID: 21157548
[TBL] [Abstract][Full Text] [Related]
5. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
[TBL] [Abstract][Full Text] [Related]
6. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
7. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M
Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935
[TBL] [Abstract][Full Text] [Related]
9. Low grade fibromyxoid sarcoma: fine-needle aspiration cytology with histologic, cytogenetic, immunohistochemical, and ultrastructural correlation.
Lindberg GM; Maitra A; Gokaslan ST; Saboorian MH; Albores-Saavedra J
Cancer; 1999 Apr; 87(2):75-82. PubMed ID: 10227597
[TBL] [Abstract][Full Text] [Related]
10. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
[TBL] [Abstract][Full Text] [Related]
11. A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of bone.
Verbeke SL; Fletcher CD; Alberghini M; Daugaard S; Flanagan AM; Parratt T; Kroon HM; Hogendoorn PC; Bovée JV
Am J Surg Pathol; 2010 Jun; 34(6):777-83. PubMed ID: 20421780
[TBL] [Abstract][Full Text] [Related]
12. Fine-needle aspiration of synovial sarcoma: criteria for diagnosis: retrospective reexamination of 37 cases, including ancillary diagnostics. A Scandinavian Sarcoma Group study.
Akerman M; Ryd W; Skytting B;
Diagn Cytopathol; 2003 May; 28(5):232-8. PubMed ID: 12722117
[TBL] [Abstract][Full Text] [Related]
13. [Imprint cytological features of soft tissue sarcomas].
Sonobe H
Rinsho Byori; 1999 Jul; 47(7):614-21. PubMed ID: 10442039
[TBL] [Abstract][Full Text] [Related]
14. G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line.
Joyner DE; Albritton KH; Bastar JD; Randall RL
J Orthop Res; 2006 Mar; 24(3):474-80. PubMed ID: 16450387
[TBL] [Abstract][Full Text] [Related]
15. Cytologic features of malignant peripheral nerve sheath tumor.
Jiménez-Heffernan JA; López-Ferrer P; Vicandi B; Hardisson D; Gamallo C; Viguer JM
Acta Cytol; 1999; 43(2):175-83. PubMed ID: 10097706
[TBL] [Abstract][Full Text] [Related]
16. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.
Krsková L; Kalinová M; Brízová H; Mrhalová M; Sumerauer D; Kodet R
Cancer Genet Cytogenet; 2009 Aug; 193(1):1-8. PubMed ID: 19602458
[TBL] [Abstract][Full Text] [Related]
17. Radiation-associated synovial sarcoma: clinicopathologic and molecular analysis of two cases.
Egger JF; Coindre JM; Benhattar J; Coucke P; Guillou L
Mod Pathol; 2002 Sep; 15(9):998-1004. PubMed ID: 12218218
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural studies in the preoperative cytologic diagnosis of soft tissue tumors.
Kindblom LG; Walaas L; Widéhn S
Semin Diagn Pathol; 1986 Nov; 3(4):317-44. PubMed ID: 3303237
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
20. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
